Research Areas

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of an Investigational Medication Compared with Ranitidine and GR88502X for the Prophylaxis of Nonsteroidal Anti-Inflammatory Drug-Associated Gastric or Duodenal Ulcers in Patients with Osteo- or Rheumatoid Arthritis and Without a History of Gastric or Duodenal Ulcers

Randomized Study Comparing Two Dose Levels of an Investigational Medication and Vehicle For An Investigational Topical Gel in the Treatment of Diabetic Patients With Neuropathic Plantar Ulcers

Randomized, Comparative Evaluation of an Investigational Medication Combined With Insulin Versus Insulin Combined With Placebo In The Treatment of Patients With Non-Insulin Dependent Diabetes Mellitus

Fifty-Six Week Open Label Study to Investigate the Long-Term Safety and Tolerability of an Investigational Medication in Patients with Non-Insulin Dependent (Type II) Diabetes Mellitus, Treated With Diet Alone

A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Group Comparison Study to Investigate the Efficacy, Tolerability and Safety of Three Different Doses of an Investigational Medication in Patients With Non-Insulin-Dependent (Type II) Diabetes Mellitus, Treated With Diet Alone

A Placebo Controlled Phase II Study to Evaluate the Efficacy and Safety of Twelve-Week Treatment with Two Different Doses of an investigational medication, in Patients with Type 2 Diabetes Mellitus Treatment With Metformin

Effects of Mixture Therapies on the Overall Glycemic Control of Patients with Type 2 Diabetes: A Comparison of an investigational medication to Once-Daily Insulin Glargine Plus Lispro

A Randomized, Double-Blind, Placebo-Controlled Trial to Assess Safety and Tolerability during Treatment of Type 2 Diabetes with Usual Diabetes Therapy and either investigational medication or Placebo

A 24-Week Randomized, Double-Blind, Multi-Center, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of an investigational Therapy When Added to Therapy of Patients with Type 2 Diabetes

A Phase II, Double-Blind, Randomized, Placebo-Controlled, Proof-of-Concept Study of the Efficacy, Safety, and Tolerability of Pioglitazone HCL (Actos) in Combination With an investigational medication in Subjects With Type 2 Diabetes

Evaluation of an Investigational Medication Versus Placebo for Gallstone Prophylaxis During Very Low Calorie Diet-Induced Rapid Weight Loss

Accupril Decision on Pharmacotherapy for Hypertension

Randomized, Comparative Evaluation of the Efficacy and Safety of an Investigational Medication Versus Glipizide in Patients With Non-Insulin Dependent Diabetes Mellitus

A Multicenter, Randomized, Double-Blind, Active Controlled Study to Compare the Effect of 52 Weeks Treatment with an investigational medication to Metformin up to 1000 mg bid in Drug Naïve Patients with Type II Diabetes.

Safety and Efficacy of an investigational medication in Patients with Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin

A Double-Blind Pilot Dose Ranging Study of an Investigational Medication Taken Once Daily Compared to Placebo and to Lovastatin Taken Once Daily in Patients With Hypercholesterolemia